Xolair 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DR26FSBL3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,522
Award facts
- Contract value 100% obligated
- $9,522.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order with a ceiling value of $9,522.18 to DMS Pharmaceutical Group Inc., a woman-owned small business, on July 29, 2026, for XOLAIR 300 MG/2 ML syringes (2 mL). The order is firm fixed price, with ultimate completion on August 19, 2026, and place of performance in Park Ridge, IL 60068. It was issued with no set-aside.
Quick answers
Who was awarded contract SPE2DR26FSBL3?
SPE2DR26FSBL3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 29, 2026.
How much is contract SPE2DR26FSBL3 worth?
The government has obligated $9,522 on SPE2DR26FSBL3.
Is contract SPE2DR26FSBL3 an order under another contract?
Yes. SPE2DR26FSBL3 is a delivery order under SPE2DR25D9311, an indefinite delivery contract.
Was contract SPE2DR26FSBL3 competed?
The extent of competition for SPE2DR26FSBL3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award